Elicio Therapeutics Launches $100M At-The-Market Offering Program, Replaces Prior $40M Sales Agreement - Elicio Therapeutics (NASDAQ:ELTX)
Published on March 16, 2026.
Elicio Therapeutics, a pharmaceutical company, has launched a $100M At-The-Market Offering Program and replaced its predecessor, the previous $40M Sales Agreement. The program aims to provide more information about the potential impact on the economy. The announcement comes as part of a broader trend towards pharmaceutical industry.
Related Articles
Josh Brown likes these defensive-oriented stocks as the market navigates tumultuous environment
Josh Brown and Sean Russo's The Best Stocks in the Market list favors defensive-oriented stocks like Ventas and Welltower amid market turmoil and ongoing consolidation trends.
Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
US stocks rose as Brent crude oil hit $100 per barrel, driven by rising gas prices and Iran's shutdown of the Strait of Hormuz, raising concerns about economic shocks.
Wall Street gets more bullish on Meta after layoffs report: ‘Zuck going for it’
Wall Street analysts are more bullish on Meta Platforms due to plans to cut 20% of its workforce to offset rising AI costs and enhance efficiency.